A once-weekly injectable medication approved by the FDA for type 2 diabetes, combining GIP and GLP-1 receptor agonist actions to improve glucose metabolism and support weight loss.

Cookie Usage

Our Website uses cookies to provide you with the best experience. Please select your preferences below. Learn more in our Privacy Policy.

NecessaryAlways active
Required for the site to function, including storing your cookie preferences.
Marketing & Analytics
Help us understand how you use our site and measure marketing performance. Includes Google Tag Manager, HubSpot, Microsoft Clarity, VWO, and Digioh.
Advertising
Used by our advertising and affiliate partners, including Commission Junction.